Last updated: September 21, 2021
Sponsor: Sivas Cumhuriyet University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Pain
Pain (Pediatric)
Acute Pain
Treatment
N/AClinical Study ID
NCT05047393
2021-06/21
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with coccygodynia
- 18-70 years old
- Having a vitamin D level determined
- Agreement to take part in the study.
Exclusion
Exclusion Criteria:
- Presence of known polyneuropathy,
- Presence of diabetes mellitus, renal failure, thyroid diseases
- Taking vitamin D replacement therapy,
- Using any of the medications used in the treatment of neuropathic pain such asduloxetine, pregabalin, gabapentin and tramadol, Having undergone an interventionalprocedure for coccygodynia within 3 months before the evaluation
Study Design
Total Participants: 51
Study Start date:
August 01, 2021
Estimated Completion Date:
February 28, 2022
Study Description
Connect with a study center
Emel Guler
Sivas,
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.